Zealand Pharma A/s
(OTC) ZLDPF
Zealand Pharma A/s Financials at a Glance
Market Cap
$3.55B
Revenue (TTM)
$9.24B
Net Income (TTM)
$6.40B
EPS (TTM)
$13.43
P/E Ratio
3.66
Dividend
$0.00
Beta (Volatility)
0.39 (Low)
Dividend
$0.00
Beta (Volatility)
0.39 (Low)
Price
$50.26
Volume
200
Open
$50.26
Price
$50.26
Volume
200
Open
$50.26
Previous Close
$50.26
Daily Range
$50.26 - $50.26
52-Week Range
$35.93 - $83.12
Dividend
$0.00
Beta (Volatility)
0.39 (Low)
Price
$50.26
Volume
200
Open
$50.26
Previous Close
$50.26
Daily Range
$50.26 - $50.26
52-Week Range
$35.93 - $83.12
ZLDPF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Zealand Pharma A/s
Industry
Biotechnology
Sector
Health CareEmployees
544
CEO
Adam Sinding Steensberg, MD, MBA
Website
www.zealandpharma.comHeadquarters
Copenhagen, 2860, DK
ZLDPF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
74%
Net Income Margin
69%
Return on Equity
56%
Return on Capital
46%
Return on Assets
42%
Earnings Yield
27.32%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.55B
Shares Outstanding
70.66M
Volume
200
Avg. Volume
2.20K
Financials (TTM)
Gross Profit
$9.17B
Operating Income
$7.14B
EBITDA
$7.17B
Operating Cash Flow
$6.52B
Capital Expenditure
$33.29M
Free Cash Flow
$6.48B
Cash & ST Invst.
$15.07B
Total Debt
$484.88M
Zealand Pharma A/s Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$34.04M
+320.6%
Gross Profit
$24.02M
+212.5%
Gross Margin
70.59%
N/A
Market Cap
$3.55B
N/A
Market Cap/Employee
$9.22M
N/A
Employees
385
N/A
Net Income
$394.41M
-17.6%
EBITDA
$529.55M
-63.9%
Quarterly Fundamentals
Net Cash
$14.07B
+72.6%
Accounts Receivable
$239.25M
+59.6%
Inventory
$0.00
-100.0%
Long Term Debt
$385.40M
+1.9%
Short Term Debt
$29.03M
+76.5%
Return on Assets
41.80%
N/A
Return on Invested Capital
45.83%
N/A
Free Cash Flow
$682.71M
-34.0%
Operating Cash Flow
$672.70M
-34.3%